Position in VCEL
as of Jun 30, 2026
· filed Jul 28, 2026
Position Value
$2,283,003
+$1,238,188 QoQ
Shares Held
51,315
+58.0% QoQ
Ownership
0.100%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#6
of 58 holders
Holding Since
Mar 2021
22 quarters on record
Voting authority
Sole 70%
Shared 0%
None 30%
Common Shares in VCEL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026TRUIST FINANCIAL CORP holds $119,348,952 across 50 Biotechnology names. VCEL ranks #7 (1.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
106,967 | $53,133,716 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
38,731 | $24,150,326 | |
| 3 | ARGX |
Argenx SE
|
3,790 | $3,516,247 | |
| 4 | EXEL |
Exelixis, Inc.
|
63,541 | $3,457,265 | |
| 5 | URGN |
UroGen Pharma Ltd.
|
72,286 | $2,660,124 | |
| 6 | JAZZ |
Jazz Pharmaceuticals plc
|
10,121 | $2,438,856 | |
| 7 | VCEL |
Vericel Corp
This page
|
51,315 | $2,283,003 | |
| 8 | RPRX |
Royalty Pharma plc
|
29,890 | $1,675,931 |
All Filings in VCEL
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,283,003 | 51,315 | Shares | Defined | 2026-07-28 | |
| 2026-03-31 | $1,044,815 | 32,478 | Shares | Defined | 2026-04-27 | |
| 2025-12-31 | $891,714 | 24,763 | Shares | Defined | 2026-02-02 | |
| 2025-09-30 | $1,944,781 | 61,798 | Shares | Defined | 2025-11-03 | |
| 2025-06-30 | $2,607,463 | 61,280 | Shares | Defined | 2025-07-18 | |
| 2025-03-31 | $2,707,585 | 60,681 | Shares | Defined | 2025-04-29 | |
| 2024-12-31 | $2,845,820 | 51,827 | Shares | Defined | 2025-01-31 | |
| 2024-09-30 | $2,159,608 | 51,115 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $2,273,720 | 49,558 | Shares | Defined | 2024-08-21 | |
| 2024-03-31 | $3,036,926 | 58,380 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $2,039,954 | 57,286 | Shares | Defined | 2024-02-02 | |
| 2023-09-30 | $1,843,867 | 55,008 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $2,025,248 | 53,906 | Shares | Defined | 2023-08-01 | |
| 2023-03-31 | $1,584,159 | 54,030 | Shares | Defined | 2023-05-05 | |
| 2022-12-31 | $1,508,175 | 57,258 | Shares | Defined | 2023-02-17 | |
| 2022-09-30 | $1,490,669 | 64,253 | Shares | Defined | 2022-10-26 | |
| 2022-06-30 | $1,359,467 | 53,990 | Shares | Defined | 2022-07-22 | |
| 2022-03-31 | $2,450,894 | 64,126 | Shares | Defined | 2022-04-22 | |
| 2021-12-31 | $367,336 | 9,347 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $516,742 | 10,589 | Shares | Defined | 2021-11-05 | |
| 2021-06-30 | $527,625 | 10,050 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $420,568 | 7,571 | Shares | Defined | 2021-05-17 | |
| No filing history on record for this holder in this stock. | ||||||